Annalisa Garbi

European Institute of Oncology

Papers

8

Total Citations

407

H-Index

7

About

Annalisa Garbi is a leading gynecologic oncologist whose research has significantly advanced the surgical management of gynecologic cancers. Her work centers on minimally invasive and robotic-assisted surgery, with a particular focus on improving outcomes for patients with endometrial, cervical, and ovarian cancers. Dr. Garbi contributed to the highly influential ESMO Clinical Practice Guidelines for non-epithelial ovarian cancer (288 citations), establishing critical standards for diagnosis and treatment. She has been a pioneer in evaluating robotic radical hysterectomy for cervical cancer, demonstrating its oncologic safety and feasibility, particularly after neoadjuvant chemotherapy. Her innovative work on sentinel lymph node detection includes a novel technique using cervical re-injection of indocyanine green to improve accuracy in endometrial cancer. Dr. Garbi has also explored the cost-effectiveness and learning curve of robotic surgery, advocating for its broader adoption. Her recent investigation into single-port robotic surgery highlights her commitment to pushing the boundaries of minimally invasive techniques. With over 400 total citations, her research continues to shape clinical practice and inspire the next generation of surgeons.

Research Focus

Key Achievements

7
H-Index
8
Papers
407
Total Citations
51
Avg Citations/Paper
🏆 Most Cited Paper
Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
288 citations · 2012
📈 Most Prolific Year: 2017 (2 Papers)
🤝 Key Collaborators: 26
🏛 Institutions: European Institute of Oncology

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago